-
New study makes key findings in potential advancement of diabetes cure
Stem cell-based therapies are some of the most promising approaches for treating type 1 diabetes (T1D), an autoimmune disease that destroys insulin-producing beta cells. Beta cells sense glucose (sugar from foods) and release insulin into the blood to regulate energy delivery to the cells all over the body. Stem cells can be transformed into replacements…
-
A safer treatment path for high-risk children to overcome food allergies
New research from BC Children’s Hospital Research Institute and the University of British Columbia (UBC) reveals a safe path to overcoming food allergies for older children or building resistance for those who can’t risk consuming allergens.
-
Government of Canda invests $20 million to improve health outcomes of children living with rare diseases
Today, the Honourable Mark Holland, Minister of Health, announced that the Government of Canada is providing $20 million over five years for the creation of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network, led by Dr. Thierry Lacaze-Masmonteil and the Maternal Infant Child and Youth Research Network (MICYRN) team. This national network, of which…
